Volume 15 Supplement 3

Gastroprotective NSAIDS

Reviews

Edited by Lee Simon (Guest Editor)

The supplement was proposed by the journal and developed by the journal in collaboration with the Guest Editor. The Guest Editor assisted the journal in preparing the outline for the project but did not have oversight of the peer review process. The Guest Editor serves as a clinical and regulatory consultant in drug development and has served as such consultant for companies which manufacture and market NSAIDS including Pfizer, Pozen, Horizon Pharma, Logical Therapeutics, Nuvo Research, Iroko Imprimis, JRX Pharma, Nuvon, Medarx, Asahi. The articles have been through the journal's standard peer review process. Publication of this supplement has been supported by Horizon Pharma Inc. Duexis (ibuprofen and famotidine) is a product marketed by the sponsor.

  1. Review

    Use of NSAIDs in treating patients with arthritis

    Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life. Of the t...

    Leslie J Crofford

    Arthritis Research & Therapy 2013 15(Suppl 3):S2

    Published on: 24 July 2013

Logo

Advertisement